Ted Barrett

Ted Barrett

Auto-generated profile, based on publicly available information

Ted Barrett

Lovelace Biomedical Research Institute, Albuquerque, NM 87108, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MBMarco Baptista
Marco Baptista
KMKalpana Merchant
Kalpana Merchant
TBTed Barrett
Ted Barrett
SBSakshi Bhargava
Sakshi Bhargava
DBDianne K. Bryce
Dianne K. Bryce
TSTodd B. Sherer
Todd B. Sherer
Morphological changes in the lungs of macaques induced by several different LRRK2 inhibitors are reversible and do not lead to lung deficits.

17 August 2022 in Science Translational Medicine
Verified
Journal Article
Open access
SLStephanie N. Langel
Stephanie N. Langel
SJSusan Johnson
Susan Johnson
CMClarissa I. Martinez
Clarissa I. Martinez
STSarah N Tedjakusuma
Sarah N Tedjakusuma
NPNadine Peinovich
Nadine Peinovich
STSean N. Tucker
Sean N. Tucker
Transmission-blocking strategies that slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and protect against coronavirus disease 2019 (COVID-19) are needed. We have developed an orally delivered adenovirus type 5–vectored SARS-CoV-2 vaccine candidate that expresses the spike protein. Here, we demonstrated that hamsters vaccinated by the oral or intranasal route had robust and cross-reactive antibody responses. We then induced a postvaccination infection by inoculating vaccinated hamsters with SARS-CoV-2. Orally or intranasally vaccinated hamsters had decreased viral RNA and infectious virus in the nose and lungs and experienced less lung pathology compared to mock-vaccinated hamsters after SARS-CoV-2 challenge. Naïve hamsters exposed in a unidirectional air flow chamber to mucosally vaccinated, SARS-CoV-2–infected hamsters also had lower nasal swab viral RNA and exhibited fewer clinical symptoms than control animals, suggesting that the mucosal route reduced viral transmission. The same platform encoding the SARS-CoV-2 spike and nucleocapsid proteins elicited mucosal cross-reactive SARS-CoV-2–specific IgA responses in a phase 1 clinical trial (NCT04563702). Our data demonstrate that mucosal immunization is a viable strategy to decrease SARS-CoV-2 disease and airborne transmission.

15 May 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SSShashi P. Singh
Shashi P. Singh
HCHitendr Chand
Hitendr Chand
RLRaymond J. Langley
Raymond J. Langley
NMNeerad Mishra
Neerad Mishra
TBTed Barrett
Ted Barrett
MSMohan Sopori
Mohan Sopori
Embryonic development is highly sensitive to xenobiotic toxicity and in utero exposure to environmental toxins affects physiological responses of the progeny. In the United States, the prevalence of allergic asthma (AA) is inexplicably rising and in utero exposure to cigarette smoke increases the risk of AA and bronchopulmonary dysplasia (BPD) in children and animal models. We reported that gestational exposure to sidestream cigarette smoke (SS), or secondhand smoke, promoted nicotinic acetylcholine receptor–dependent exacerbation of AA and BPD in mice. Recently, perinatal nicotine injections in rats were reported to induce peroxisome proliferator-activated receptor γ–dependent transgenerational transmission of asthma. Herein, we show that first generation and second generation progeny from gestationally SS-exposed mice exhibit exacerbated AA and BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor γ levels. Lungs from these mice show strong eosinophilic infiltration, excessive Th2 polarization, marked airway hyperresponsiveness, alveolar simplification, decreased lung compliance, and decreased lung angiogenesis. At the molecular level, these changes are associated with increased RUNX3 expression, alveolar cell apoptosis, and the antiangiogenic factor GAX, and decreased expression of HIF-1α and proangiogenic factors NF-κB and VEGFR2 in the 7-d first generation and second generation lungs. Moreover, the lungs from these mice exhibit lower levels of microRNA (miR)-130a and increased levels of miR-16 and miR-221. These miRs regulate HIF-1α–regulated apoptotic, angiogenic, and immune pathways. Thus the intergenerational effects of gestational SS involve epigenetic regulation of HIF-1α through specific miRs contributing to increased incidence of AA and BPD in the progenies.

14 August 2013 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
KAKathy H Abbott-Banner
Kathy H Abbott-Banner
AHAnthony Holmes
Anthony Holmes
IAIan Adcock
Ian Adcock
NRNavin L Rao
Navin L Rao
EBEdward Barrett
Edward Barrett
RKRichard Knowles
Richard Knowles